Evidence map›Paper›PMID 15841270›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2005

Bioprospecting: a CAM Frontier.

Edwin L Cooper

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Corals and their potential applications to integrative medicine.Evidence-based complementary and alternative medicine : eCAM · 2014
    Article
  2. Animal-based remedies as complementary medicines in the semi-arid region of northeastern Brazil.Evidence-based complementary and alternative medicine : eCAM · 2011
    Article
  3. Article
  4. Sustainable traditional medicine: taking the inspirations from ancient veterinary science.Evidence-based complementary and alternative medicine : eCAM · 2011
    Article
  5. Article
  6. eCAM: Darwin and Metchnikoff.Evidence-based complementary and alternative medicine : eCAM · 2009
    Article
  7. Article
  8. Article
  9. eCAM: An Emerging Linkage with Ethnopharmacology?Evidence-based complementary and alternative medicine : eCAM · 2008
    Article
  10. Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers.Evidence-based complementary and alternative medicine : eCAM · 2008
    Article
  11. The immune system and complementary and alternative medicine.Evidence-based complementary and alternative medicine : eCAM · 2007
    Article
  12. Colony collapse disorder may affect complementary and alternative medicine.Evidence-based complementary and alternative medicine : eCAM · 2007
    Article
  13. On the Road to an Impact Factor for eCAM.Evidence-based complementary and alternative medicine : eCAM · 2007
    Article
  14. Regional Strength in CAM.Evidence-based complementary and alternative medicine : eCAM · 2006
    Article
  15. ECAM is waiting for eCAM.Evidence-based complementary and alternative medicine : eCAM · 2005
    Article
  16. The systemic theory of living systems and relevance to CAM: the theory (Part III).Evidence-based complementary and alternative medicine : eCAM · 2005
    Article
  17. eCAM benefits from diversity that derives from CAM.Evidence-based complementary and alternative medicine : eCAM · 2005
    Article
  18. CAM, eCAM, Bioprospecting: The 21st Century Pyramid.Evidence-based complementary and alternative medicine : eCAM · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Edwin L Cooper

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID15841270
PMCPMC1062155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.